UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Frontiers in medicine, 2022-02, Vol.9, p.823900-823900

2022

Volltextzugriff (PDF)

Current stage in inflammatory bowel disease: What is next?

World journal of gastroenterology : WJG, 2015-10, Vol.21 (40), p.11282-11303

Gonzalo Jesús Gómez-Gómez ángeles Masedo Carmen Yela Maria del Pilar Martínez-Montiel Bego?a Casís

2015

Volltextzugriff (PDF)

Therapy with stem cells in inflammatory bowel disease

World journal of gastroenterology : WJG, 2014-02, Vol.20 (5), p.1211-1227

2014

Volltextzugriff (PDF)

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study

Therapeutic advances in gastroenterology, 2021-11, Vol.14, p.17562848211056157-17562848211056157

2021

Volltextzugriff (PDF)

Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic

Revista española de enfermedades digestivas, 2022-01, Vol.114 (1), p.58-59

2022

Volltextzugriff (PDF)

Inflammatory bowel disease and solid organ transplantation

Revista española de enfermedades digestivas, 2021-01, Vol.113 (1), p.60-64

2021

Volltextzugriff (PDF)

Pharmacologic therapy for inflammatory bowel disease refractory to steroids

Clinical and Experimental Gastroenterology, 2015-01, Vol.8 (default), p.257-269

2015

Volltextzugriff (PDF)

Satisfaction degree comparison of patients treated at Inflammatory Bowel Disease Unit (IBDU) of the Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic

Revista española de enfermedades digestivas, 2021

2021

Volltextzugriff (PDF)

Increased risk of thiopurine‐related adverse events in elderly patients with IBD

Alimentary pharmacology & therapeutics, 2019-10, Vol.50 (7), p.780-788

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry

Journal of Crohn's and colitis, 2023-01, Vol.17 (1), p.83-91

2023

Volltextzugriff (PDF)

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

Journal of Crohn's and colitis, 2020-09, Vol.14 (9), p.1290-1298

2020

Volltextzugriff (PDF)

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry

Journal of Crohn's and colitis, 2015-12, Vol.9 (12), p.1063-1070

2015

Volltextzugriff (PDF)

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Inflammatory bowel diseases, 2017-08, Vol.23 (8), p.1394-1402

2017

Volltextzugriff (PDF)

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Inflammatory bowel diseases, 2020-03, Vol.26 (4), p.606-616

2020

Volltextzugriff (PDF)

The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU

Inflammatory bowel diseases, 2024-03

2024

Volltextzugriff (PDF)

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial

Journal of Crohn's and colitis, 2017-10, Vol.11 (11), p.1293-1301

2017

Volltextzugriff (PDF)

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases

Journal of Crohn's and colitis, 2012-06, Vol.6 (5), p.518-523

2012

Volltextzugriff (PDF)

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2017-07, Vol.11 (7), p.792-800

2017

Volltextzugriff (PDF)

SEGURIDAD DE LAS VACUNAS DE VIRUS VIVOS EN NIÑOS EXPUESTOS A FÁRMACOS BIOLÓGICOS PARA LA ENFERMEDAD INFLAMATORIA INTESTINAL (EII) EN EL ÚTERO O DURANTE LA LACTANCIA MATERNA

Gastroenterología y hepatología, 2023-03, Vol.46, p.S27-S27

2023

Volltextzugriff (PDF)

Serial Tuberculin Skin Test Improves the Detection of Latent Tuberculosis Infection in Inflammatory Bowel Disease Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S611-S611

2017

Volltextzugriff (PDF)

Su1957 - Serial Tuberculin Skin Test Improves the Detection of Latent Tuberculosis Infection in Inflammatory Bowel Disease Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S611-S611

2017

Volltextzugriff (PDF)

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

Gastroenterología y hepatología, 2011-08, Vol.34 (7), p.443-448

2011

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Gastroenterology & Hepatology
(22)
Humans
(17)
Inflammatory Bowel Disease
(14)
Adult
(12)
Crohn's Disease
(12)
Female
(12)
Male
(12)
Gastroenterology And Hepatology
(10)
Ulcerative Colitis
(10)
Middle Aged
(9)
Retrospective Studies
(8)
Adalimumab
(7)
Aged
(7)
Inflammatory Bowel Diseases - Drug Therapy
(6)
Immunosuppressive Agents - Therapeutic Use
(5)
Inflammatory Bowel Diseases - Epidemiology
(5)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Current stage in inflammatory bowel disease: What is next?

Therapy with stem cells in inflammatory bowel disease

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study

Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic

Inflammatory bowel disease and solid organ transplantation

Pharmacologic therapy for inflammatory bowel disease refractory to steroids

Satisfaction degree comparison of patients treated at Inflammatory Bowel Disease Unit (IBDU) of the Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic

Increased risk of thiopurine‐related adverse events in elderly patients with IBD

Delphi consensus statement: Quality indicators for Inflammatory Bowel Disease Comprehensive Care Units

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn’s patients: Results of the APPRECIA trial

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

SEGURIDAD DE LAS VACUNAS DE VIRUS VIVOS EN NIÑOS EXPUESTOS A FÁRMACOS BIOLÓGICOS PARA LA ENFERMEDAD INFLAMATORIA INTESTINAL (EII) EN EL ÚTERO O DURANTE LA LACTANCIA MATERNA

Serial Tuberculin Skin Test Improves the Detection of Latent Tuberculosis Infection in Inflammatory Bowel Disease Patients

Su1957 - Serial Tuberculin Skin Test Improves the Detection of Latent Tuberculosis Infection in Inflammatory Bowel Disease Patients

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

Suchergebnisse filtern